Commentary on: "Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study"

被引：0
|
作者：
Bright, Heber Rew [1 ]
Chandy, Sujith John [2 ]
George, Renu [3 ]
机构：
[1] Christian Med Coll & Hosp, Dept Pharm, Vellore, India
[2] Christian Med Coll & Hosp, Dept Pharmacol, Vellore, India
[3] Christian Med Coll & Hosp, Dept Dermatol, Vellore, India
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
10.2340/actadv.v103.13348
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study
    Haisma, Marjolijn S.
    Logendran, Mathanhy
    Bos, Jens
    V.d. Vegt, Bert
    Horvath, Barbara
    DE Vos, Stijn
    Bock, Geertruida H. D. E.
    Hak, Eelko
    Racz, Emoke
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [2] Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort Study
    Yang, Avery Shuei-He
    Djebarri, Leila
    Lee, Chaw Ning
    Granados, Denis
    Moneim, Mohamed Abdel
    Shao, Shih-Chieh
    Lin, Swu-Jane
    Liao, Tzu-Chi
    Lin, Hung-Wei
    Lai, Edward Chia-Cheng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (11)
  • [3] Use of Hydrochlorothiazide and Risk of Skin Cancer
    Pottegard, Anton
    Hallas, Jesper
    Arnspang, Sidsel
    Gaist, David
    Olesen, Morten
    Svendsen, Mathias T.
    Habel, Laurel A.
    Friedman, Gary D.
    Schmidt, Sigrun A. J.
    Holmich, Lisbet R.
    Friis, Soren
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 473 - 473
  • [4] Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
    Steenhuis, Dennis
    de Vos, Stijn
    Bos, Jens
    Hak, Eelko
    CARDIOVASCULAR THERAPEUTICS, 2022, 2022
  • [5] Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data
    Kim, J. C.
    Kim, Y. C.
    Choi, J. W.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (04) : 680 - 686
  • [6] Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer
    Julie Rouette
    Hui Yin
    Anton Pottegård
    Krishnarajah Nirantharakumar
    Laurent Azoulay
    Drug Safety, 2021, 44 : 245 - 254
  • [7] Use of hydrochlorothiazide and risk of melanoma and nonmelanoma skin cancer
    Rouette, Julie
    Yin, Hui
    Pottegard, Anton
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 570 - 570
  • [8] Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer
    Rouette, Julie
    Yin, Hui
    Pottegard, Anton
    Nirantharakumar, Krishnarajah
    Azoulay, Laurent
    DRUG SAFETY, 2021, 44 (02) : 245 - 254
  • [9] Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study
    Anton Pottegård
    Sidsel Arnspang Pedersen
    Sigrun Alba Johannesdottir Schmidt
    Chaw-Ning Lee
    Chao-Kai Hsu
    Tzu-Chi Liao
    Shih-Chieh Shao
    Edward Chia-Cheng Lai
    British Journal of Cancer, 2019, 121 : 973 - 978
  • [10] Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population
    Tiba, Ana P. L.
    Cury-Martins, Jade
    Miyashiro, Denis R.
    Sanches, Jose A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E213 - E214
12345